跳至主要内容
临床试验/NCT04292275
NCT04292275终止不适用

A Randomized, Open-Label, Standard-of-Care-Controlled, Multicenter Study to Evaluate Digital Health Data Use in Managing Guideline-Directed Heart Failure Therapy

Amgen16 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2020年3月6日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Amgen
入组人数
18
试验地点
16
主要终点
Time to Change or Decision That Heart Failure Therapy is Optimal

研究概览

简要总结

A study evaluating the impact of remotely collected data, measured using digital technologies, on the use of guideline-recommended heart failure therapy in adult participants with heart failure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • History of chronic heart failure.
  • Ejection fraction equal to or below 40%.
  • New York Heart Association (NYHA) class II to class III.
  • Enrollment during or within 30 days after a hospitalization, emergency department, or urgent, unscheduled clinic/office visit with primary diagnosis of heart failure.

排除标准

  • Has received a major organ transplant (e.g., lung, liver, heart, bone marrow, kidney).
  • Currently in an investigational device or drug study.
  • Unwilling or unable to wear a digital wrist watch device for measuring blood pressure and other parameters during waking hours.

结局指标

主要结局

Time to Change or Decision That Heart Failure Therapy is Optimal

时间窗: Randomization to 6 months

Area under the curve (AUC) will be calculated for a daily dose-related medication score for beta-blocker, angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker/angiotensin neprilysin inhibitor, and aldosterone antagonist therapy.

次要结局

  • Time to change or decision that heart failure therapy is optimal(Baseline to 6 months)
  • Numerical Health Information Technology Usability Evaluation Scale for Healthcare Provider Scores (Health-ITUES-HCP)(Week 24)
  • Change from Baseline in Kansas City Cardiomyopathy Questionnaire (KCCQ-23) Scores(Baseline and Week 24)
  • Numerical Health Information Technology Usability Evaluation Scale for Participants (Health-ITUES-Subject) Scores(Week 24)
  • Change in Numerical Rating of Subject Satisfaction with Heart Failure Therapy(Baseline and Week 24)

研究者

发起方
Amgen
申办方类型
Industry
责任方
Sponsor

研究点 (16)

Loading locations...

相似试验